SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
45,600
+500 (1.11%)
At close: Jun 2, 2025, 3:30 PM KST

SK bioscience Revenue

SK bioscience had revenue of 154.56B KRW in the quarter ending March 31, 2025, with 594.00% growth. This brings the company's revenue in the last twelve months to 399.83B, up 7.72% year-over-year. In the year 2024, SK bioscience had annual revenue of 267.55B, down -27.59%.

Revenue (ttm)
399.83B
Revenue Growth
+7.72%
P/S Ratio
8.94
Revenue / Employee
406.33M
Employees
984
Market Cap
3,573.63B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024267.55B-101.96B-27.59%
Dec 31, 2023369.51B-87.22B-19.10%
Dec 31, 2022456.73B-472.28B-50.84%
Dec 31, 2021929.00B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition